BD Nexiva™ Closed IV Catheter System is not just a catheter. BD Nexiva™ Closed IV Catheter System is an all-in-one PIVC, combining four individual devices in one: IV catheter, extension set, stabilization device, and needle-free connector/s. It is clinically demonstrated to have longer dwell times – dwelling up to 144 hours – and reduced complications versus an open system.*
*with a PTFE catheter
Support
Sales
1.844.8.BD.LIFE (1.844.823.5433)
Thank you for contacting our sales team!
A sales representive will get in touch with you shortly.
Ordering
1.714.283.2228
5 a.m. to 4 p.m. PT
1.714.283.8424
oem@carefusion.com
Customer Service
1.844.8.BD.LIFE (1.844.823.5433)
1.800.847.2220
- Overview
- Best Practices
- Products & Accessories
- EIFU & Resources
true
BD Vialon™ catheter material
Proprietary BD Vialon™ Catheter Material softens, enabling longer dwell time and reducing the chance of phlebitis up to 69%.
BD Instaflash™ needle technology
Provides quick blood visualization that may help improve insertion success and therefore reduce insertion attempts.
Built-in stabilization platform‡
BD Nexiva* with an integrated extension tubing and stabilization platform is designed to reduce manipulation and movement at the site and has been shown to reduce dislodgement and phlebitis
Pre-attached extension set
Shown to significantly reduce blood exposure during insertion compared to an open system 2* and aligns with INS guidelines. 4
Reduces accidental dislodgement
The BD Nexiva* with the built-in stabilization platform reduces dislodgement by 84%1†
Lessens blood exposure
By choosing the BD Nexiva {*}, you can reduce the risk of complications and blood exposure as well as preserve sites*
*Compared to an open system with a PTFE catheter
Lowers chance of mechanical phlebitis
The BD Nexiva {*} demonstrated a 29% reduction in phlebitis rates when compared to an open system*
*with a PTFE catheter
Dwells longer
In a randomized study comparing the BD Nexiva {*} to an open catheter system*, among peripheral IV catheters in place for over 24 hours, the median dwell time for BD Nexiva™ {*} was up to 144 hours versus 96 hours for the open system
Preserves sites
BD Nexiva {*} is an all-in-one PIVC shown to preserve sites for longer
May help reduce cost and delays in treatment
BD Nexiva {*} has been shown to reduce costs and reduce treatment delays in clinical studies.
BD Nexiva™: Traditional vs closed IV catheter insertion
Centers for Disease Control and Prevention
Catheter stabilization is recognized as an intervention to decrease the risk for phlebitis, catheter migration and dislodgement and may be advantageous in preventing catheter-related bloodstream infections (CRBSIs).3
Infusion Therapy Standards of Practice
Recommend limiting the use of add-on devices to reduce the potential for contamination, additional manipulation, and disconnection.5
Increased clinician safety
98% reduced blood exposure during insertion due to the BD Nexiva IV catheter preassembled system.2*
Increased catheter stabilization
Clinically demonstrated to reduce accidental dislodgement,2‡ meeting Infusion Nursing Society standards4 and CDC guidelines5 for catheter stabilization.
Reduced rate of complications
In a clinical study, results demonstrated a significant reduction in the rate of phlebitis (grade 2 or higher), PIVC-related complications, and infiltration in the closed system versus the open system group.1
-
Nexiva Dual Port with Q-Syte, 18G x 1.75"
-
BD Nexiva™ Closed IV Catheter System - Dual Port with BD™ Q-Syte Needle-free Connector, 20 G x 1.75 in. (1.1 mm x 44 mm) with BD Vialon™ Catheter Material, sterile, single use
-
BD Nexiva™ Closed IV Catheter System - Dual Port with BD™ Q-Syte Needle-free Connector, 20 G x 1.25 in. (1.1 mm x 32 mm) with BD Vialon™ Catheter Material, sterile, single use
-
BD Nexiva™ Closed IV Catheter System - Dual Port with BD™ Q-Syte Needle-free Connector, 22 G x 1.00 in. (0.9 mm x 25 mm) with BD Vialon™ Catheter Material, sterile, single use
-
BD Nexiva™ Closed IV Catheter System - Dual Port with BD™ Q-Syte Needle-free Connector, 24 G x 0.75 in. (0.7 mm x 19 mm) with BD Vialon™ Catheter Material, sterile, single use
-
Nexiva Dual Port with Q-Syte, 24G x 0.56"
-
BD Nexiva™ Closed IV Catheter System - Single Port, 18 G x 1.75 in. (1.3 mm x 44 mm) with BD Vialon™ Catheter Material, sterile, single use
-
BD Nexiva™ Closed IV Catheter System - Single Port, 20 G x 1.75 in. (1.1 mm x 44 mm) with BD Vialon™ Catheter Material, sterile, single use
-
BD Nexiva™ Closed IV Catheter System - Single Port, 20 G x 1.25 in. (1.1 mm x 32 mm) with BD Vialon™ Catheter Material, sterile, single use
-
BD Nexiva™ Closed IV Catheter System - Single Port, 20 G x 1.00 in. (1.1 mm x 25 mm) with BD Vialon™ Catheter Material, sterile, single use
-
BD Nexiva™ Closed IV Catheter System - Single Port, 22 G x 1.75 in. (0.9 mm x 44 mm) with BD Vialon™ Catheter Material, sterile, single use
-
Nexiva Single Port, 22G x 1.0"
-
BD Nexiva™ Closed IV Catheter System - Single Port, 24 G x 0.75 in. (0.7 mm x 19 mm) with BD Vialon™ Catheter Material, sterile, single use
-
Nexiva Single Port, 24G x 0.56"
-
BD Nexiva™ Closed IV Catheter System - Dual Port with BD™ Q-Syte Needle-free Connector, 18 G x 1.25 in. (1.3 mm x 32 mm) with BD Vialon™ Catheter Material, sterile, single use
-
BD Nexiva™ Closed IV Catheter System - Dual Port with BD™ Q-Syte Needle-free Connector, 20 G x 1.00 in. (1.1 mm x 25 mm) with BD Vialon™ Catheter Material, sterile, single use
-
BD Nexiva™ Closed IV Catheter System - Single Port, 18 G x 1.25 in. (1.3 mm x 32 mm) with BD Vialon™ Catheter Material, sterile, single use
false
Literature
BD's collection of literature on industry and on our offerings gives you information you can use to continue striving for excellence.
Learn more
Training
BD offers training resources to help improve your clinical practices as part of our goal of advancing the world of health.
Learn more
Events
BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events that excel in advancing the world of health™.
Learn more
Case Studies
BD promotes clinical excellence by providing various resources on best practices, clinical innovations and industry trends in healthcare.
Learn more
Literature
BD's collection of literature on industry and on our offerings gives you information you can use to continue striving for excellence.
Learn more
Training
BD offers training resources to help improve your clinical practices as part of our goal of advancing the world of health.
Learn more
Events
BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events that excel in advancing the world of health™.
Learn more
Case Studies
BD promotes clinical excellence by providing various resources on best practices, clinical innovations and industry trends in healthcare.
Learn more
false
Notes
*Compared to an open system.
**Results and savings may vary for other institutions.
†Compared with an FEP catheter.
‡When used with a specially designed 3M™ Tegaderm™ IV site securement dressing.
§Compared with B. Braun Introcan Safety® catheter with Bard Statlock® IV Ultra stabilization device.
||Compared with 96 hours in an open system.
¶Compared with a non-blood control catheter.
References
- González López J, Arribi Vilela A, Fernández Del Palacio E, et al. Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters: a randomized study. J Hosp Infect. 2014;86(2):117-126.
- Bausone-Gazda D, Lefaiver CA, Walters SA. A randomized controlled trial to compare the complications of 2 peripheral intravenous catheter stabilization systems. J Infus Nurs. 2010;33(6):371-384.
- Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. Ann Intern Med. 1991;114(10):845-854.
- Infusion Nurses Society. Infusion therapy standards of practice. J Infus Nurs. 2016:39(1S).
- O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. CDC. 2011:16.
BD-3595 (03/23)